Nuclear Factor-kB p65 (NFkBP65) (Middle Region) Peptid
NFkBP65
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle NF-kB p65 (NFkBP65) Produkte
- NF-kB p65 (NFkBP65) (Nuclear Factor-kB p65 (NFkBP65))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RELA antibody (Catalog #: ARP30371_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
Nuclear Factor-kB p65 (NFkBP65) peptide
NFkBP65 Reaktivität: Human CP Sodium azide
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NF-kB p65 (NFkBP65) (Nuclear Factor-kB p65 (NFkBP65))
- Synonyme
- C-Rel Peptide, NFKB3 Peptide, p65 Peptide, NFkB Peptide, c-rel Peptide, zgc:100833 Peptide, Xrel2 Peptide, Xrel3 Peptide, rel Peptide, rel-A Peptide, rel2 Peptide, rel3 Peptide, v-rel Peptide, xrel Peptide, REL proto-oncogene, NF-kB subunit Peptide, RELA proto-oncogene, NF-kB subunit Peptide, v-rel reticuloendotheliosis viral oncogene homolog A (avian) Peptide, v-rel avian reticuloendotheliosis viral oncogene homolog Peptide, v-rel avian reticuloendotheliosis viral oncogene homolog L homeolog Peptide, REL Peptide, RELA Peptide, Rela Peptide, Rel Peptide, rel Peptide, rel.L Peptide
- Hintergrund
-
P65 is a subunit of the nuclear factor kappa-B, a second messenger, which activates the transcription of a number of genes in multiple tissues. The inhibitory effect of I-kappa-B upon NF-kappa-B in the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. NFKB1 (MIM 164011) or NFKB2 (MIM 164012) is bound to REL (MIM 164910), RELA, or RELB (MIM 604758) to form the NFKB complex. The p50 (NFKB1)/p65 (RELA) heterodimer is the most abundant form of NFKB. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA, MIM 164008 or NFKBIB, MIM 604495), which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA, MIM 600664, or IKBKB, MIM 603258) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NFKB complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T, R is an A or G purine, and Y is a C or T pyrimidine).[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-1760 M62399.1 8-1767
Alias Symbols: MGC131774, NFKB3, p65
Protein Interaction Partner: AES,BIRC3,CARM1,CCND1,CHEK1,CHUK,CREBBP,CREBBP,CXCL10,EGR1,EP300,EP300,FOS,IL8,ING4,JUN,NCOA3,NFKB1,NFKB1,NFKBIA,NFKBIA,NFKBIB,NFKBIB,SLC1A2,TERT,TLE1,AATF,ACTL6A,AES,AHR,AKAP8,APBA2,AR,BRCA1,BTK,BTRC,CALM1,CAMK4,CARM1,CDK9,CEBPB,CEBPD,CHEK1,CHUK,COMMD1,CREBBP,CSNK2A1,DDX1,DHX9,EGR1,EP300,ESR1,ETHE1,FAF1,FOS,FUS,GTF2B,HDAC1,HDAC2,HDAC3,HEXIM1,HMGA2,HMGB1,IKBKB,ING4,IRAK1BP1,IRF1,IRF2,IRF3,JUN,KAT2B,KPNA2,MAP2K6,MAP3K7,MAP3K8,MEN1,MST1R,MTPN,MYC,NCOA3,NCOR2,NFKB1,NFKB2,NFKBIA,NFKBIB,NFKBIE,NKRF,NKX2-1,NOTCH1,NR3C1,PARP1,PDCD11,PGR,PIAS1,PIAS3,PIN1,PML,POU2F1,PPARA,PPP1R13L,PPP2CA,PPP2R1B,PPP4C,PRKACA,PRKCZ,PRTN3,REL,RELA,RELB,REPS2,RFC1,RNF25,RPS6KA5,RXRA,SIRT1,SNIP1,SOCS1,SP1,SRF,STAT1,STAT3,STAT6,TAF1,TAF11,TAF4B,TAF6,TBK1,TBP,TERT,TNIP2,TP53BP1,TP53BP2,TRIB3,TRIP4,TSC22D3,TWIST1,UNC5CL,AES,AHR,AKAP8L,APBA2,ASCC1,ASCC2,ASCC3,BARD1,BRCA1,BTRC,CDK9,CEBPB,CEBPD,COMMD1,CREBBP,CSNK2A1,CSNK2A2,DHX9,EGR1,EP300,ETHE1,FOS,FUS,GTF2B,HDAC1,HDAC2,HDAC3,HEXIM1,HMGA2,HMGB1,Hdac1,ING4,IQGAP2,IRF2,IRF8,IRF9,ITGB3BP,JUN,KDM2A,KPNA2,MAP3K8,MEN1,MTPN,MYC,NCF1,NCOA6,NCOR2,NFKB1,NFKB2,NFKBIA,NFKBIB,NFKBIE,NKRF,NKX2-1,NOTCH1,NR3C1,NSD1,PARP1,PDLIM2,PGR,PIAS3,PML,POU2F1,PPARA,PPP1R13L,PPP2CA,PPP2CB,PPP4C,PRKCZ,REL,RELA,RELB,RFC1,RNF25,RXRA,SOCS1,SP1,SRF,STAT3,TAF1,TAF11,TAF4B,TAF6,TBK1,TBP,TERT,TLE1,TNIP2,TRIB3,TWIST1,UBC,UNC5CL
Protein Size: 551 - Molekulargewicht
- 60 kDa
- Gen-ID
- 5970
- NCBI Accession
- NM_021975, NP_068810
- UniProt
- Q04206
-
Sie sind hier:
